To the Members,
The Directors have pleasure in presenting to you the Thirty Eighth (38th)
Annual Report of Trigyn Technologies Limited
(the "Company" or "TTL") along with the audited
financial statements for the financial year ended March consolidated performance of the
Company and its subsidiaries has been referred to wherever required.
1. SUMMARY OF FINANCIAL RESULTS
Financial Results for the period ended March 31, 2024 are given below:
(Rs. in Lakhs)
|
STANDALONE |
CONSOLIDATED |
Particular |
Year ended |
Year ended |
Year ended |
Year ended |
|
March-24 |
March-23 |
March-24 |
March-23 |
Total income |
17,526.55 |
17,251.95 |
127,966.23 |
127,272.44 |
Operating expenses |
18,040.26 |
17,223.64 |
120,060.49 |
119,807.31 |
Earnings before
interest, tax, depreciation, and amortisation (EBITDA) |
(513.71) |
28.31 |
7,905.74 |
7,465.13 |
Other Income |
3,066.31 |
2,625.42 |
1,199.30 |
649.05 |
Interest and finance charges |
104.63 |
159.92 |
165.71 |
224.22 |
Depreciation |
416.74 |
406.63 |
687.68 |
680.19 |
ECL & Provision for doubtful
advances |
1,119.66 |
1,386.26 |
4,430.59 |
1,386.26 |
Profit before
Exceptional and Extra-ordinary item and before taxes |
911.56 |
700.93 |
3,821.06 |
5,823.50 |
Exceptional Items |
(4.42) |
(5.55) |
- |
- |
Profit/(loss)before
exceptional items and tax |
907.14 |
695.38 |
3,821.06 |
5,823.50 |
Taxation |
256.08 |
265.21 |
1,824.73 |
2,355.78 |
Net profit / (loss) after tax
for the period |
651.06 |
430.17 |
1,996.33 |
3,467.72 |
Other comprehensive income |
(733.46) |
(82.37) |
25.38 |
3,871.45 |
Total comprehensive income |
(82.40) |
347.81 |
2,021.71 |
7,339.18 |
2. COMPANY'S PERFORMANCE
During the year under review on a standalone basis your company
achieved Total Revenue of 17,526.55 lakhs as compared to 17,251.95 lakhs in the
previous year. The net profit on standalone basis stood at 651.06 lakhs as compared to
430.17 lakhs in the previous year.
During the year under review on a consolidated basis your company
achieved Total Revenue of 127,966.23 lakhs as compared to 1,27,272.44 lakhs in the
previous year. The net profit on consolidated basis stood at 1,996.33 lakhs as compared
to 3,467.72 lakhs in the previous year.
For the year ended March 31, 2024 on standalone basis EPS stood at
2.11/- and on Consolidated basis EPS stood at 6.48/-.
3. SHARE CAPITAL
The paid-up Equity Share Capital of the Company as on March 31, 2024 is
307,857,360 divided into 30,785,736 equity shares of 10/- each. The paid-up share
capital of the Company held by the Promoters is 44.51% as on March 31, 2024, all in
dematerialized form.
The Company has not issued any equity shares with differential rights,
sweat equity shares or bonus shares. The Company has only one class of equity shares with
face value of 10 each, ranking pari -passu.
4. DIVIDEND
In view to conserve cash / resources for the growth / future expansion,
your directors have not recommended any dividend for the year under review.
5. DEPOSIT FROM PUBLIC
The Company has not accepted any deposits from the public and as such,
no amount on account of principal or interest on deposits from the public was outstanding
as on the date of the balance sheet.
6. TRANSFER TO RESERVES
The Board of Directors has decided to transfer
NILamounttoGeneralReserveinthefinancial . year 2023-2024
7. TRANSFER TO INVESTOR EDUCATION AND PROTECTION FUND
During the year under review, the Company was not required to transfer
unpaid/unclaimed dividend, shares to the Investor Education and Protection Fund (IEPF)
Authority of the Central Government of India.
8. MATERIAL CHANGES AND COMMITMENTS AFFECTING FINANCIAL POSITION
BETWEEN THE END OF THE FINANCIAL YEAR AND DATE OF REPORT
There have been no material changes and commitments affecting financial
position between the end of the financial year and as on the date of report.
9. HUMAN RESOURCE MANAGEMENT
Human Resource has always been the prime focus at Trigyn. The
organization strongly believes that human resources are the key factor to achieve success
in the business. At Trigyn we recruit, train and recompense people according to a strategy
that aims to organize our businesses effectively; accelerate development of our people;
grow and strengthen our leadership capabilities; and enhance employee performance through
strong engagement. Regular feedback is obtained from every participant to determine
whether the training is effective, or any further training is needed.
To cater to the efficiencyof the employees, Trigyn aids them in
Certification. Trigyn also provides online courses for the employees so that they can
perform more efficiently.
Trigyn deploys its intellectual capability across the globe to create
and deliver IT solutions that make a positive business impact for its customers. The key
resource to make this happen is the talent within the organization. At Trigyn, we believe
in nurturing our employees and hence undertake HR programs that focus on all aspects of
the lifecycle of an employee which helps us attract and retain our best talent. The
company continues to grow its global scale and footprint with a diverse talent base of
employees, deployed across the globe. Efficient systems, processes and continuous
investments in technology help the company manage this complexity of a large, distributed
and diverse workforce.
10. SEXUAL HARASSMENT AT WORKPLACE
To foster a positive workplace environment, free from harassment of any
nature, we have institutionalized the Sexual Harassment Committee, through which we
address complaints of sexual harassment at the workplace. The Company has zero tolerance
for sexual harassment at workplace and thus has adopted a policy on prevention prohibition
and redressal of sexual harassment at workplace in line with the provisions of the Sexual
Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013 and the
rules thereunder for prevention and redressal of complaints of sexual harassment at
workplace.
During the financial year 2023-2024, the Company has received no
complaints on sexual harassment.
11. PARTICULARS OF EMPLOYEES
The disclosure pertaining to remuneration and other details are
required to be furnished pursuant to Section 197(12) read with rule 5(1) of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014 are as given below: a.
The ratio of the remuneration of each Director to the median remuneration of the employees
of the Company for the financial year:
|
Ratio to
median |
Directors |
|
|
remuneration |
Mr. CH V.V. Prasad |
0.23 |
Mr. Vivek Khare |
0.43 |
Dr. B.R. Patil |
0.43 |
Mr. A. R. Ansari* |
0.32 |
Dr. Raja Mohan Rao |
- |
Mr. Kodumudi Sambamurthi Sripathi |
0.26 |
Ms. Bhavana Rao |
- |
Ms. Lakshmi Potluri |
0.09 |
Mr. R. Ganapathi # |
0.12 |
Mr Ishwar Halalli** |
0.06 |
Mr Syed Ahmed Sultan** |
0.09 |
Mr Vijay Mallya** |
0.09 |
*Mr. A.R Ansari was an Independent Director upto 31st
January 2024
** Mr. Ishwar Halalli, Mr. Syed Ahmed Sultan, and Mr. Vijay Mallya were
appointed as an Independent Director through Postal Ballot with effect from January 06,
2024.
# Includes Sitting Fees Rs. 1.40 Lakhs & Consultancy Fees (in
Professional Capacity) Rs. 40.00 Lakhs Sitting Fees has increased from Rs. 20,000 to Rs.
35,000 during the year w.e.f August 2023. b. The percentage increase in remuneration of
each Director, Chief Executive Officer, Chief Financial Officer, Company Secretary in the
financial year:
Directors*,
Chief Executive Officer, Company Secretary |
Chief Financial
Officer, and |
% increase in remuneration in the financial year |
Mr.CH V.V.Prasad |
|
40.00 |
Mr. Vivek Khare |
|
64.06 |
Dr. B.R. Patil |
|
64.06 |
Mr. A. R. Ansari* |
|
13.24 |
Dr. Raja Mohan Rao |
|
- |
Mr. Kodumudi Sambamurthi Sripathi |
|
57.50 |
Ms. Bhavana Rao |
|
- |
Ms. Lakshmi Potluri |
|
- |
R. Ganapathi # |
|
(22.22) |
Mr Ishwar Halalli** |
|
- |
Mr Syed Ahmed Sultan** |
|
- |
Mr Vijay Mallya** |
|
- |
Mr Dilip Hanumara*** |
|
- |
Mr Amin Bhojani ## |
|
3.94 |
Mr Mukesh Tank ## |
|
2.09 |
*Mr. A.R Ansari was an Independent Director upto 31st
January 2024.
** Mr. Ishwar Halalli, Mr. Syed Ahmed Sultan, and Mr. Vijay Mallya were
appointed as an Independent Director through Postal Ballot with effect from January 6,
2024.
# Includes Sitting Fees Rs. 1.40 Lakhs & Consultancy Fees (in
Professional Capacity) Rs. 40.00 Lakhs. ## The above percentage increase in the
remuneration excludes reimbursement of expenses and continuity pay for FY 2023-24 Rs. 10
Lakhs each to Mr. Amin Bhojani & to Mr. Mukesh Tank.
*** Mr Dilip Hanumara was CEO upto November 30, 2023.
Sitting Fees has increased from Rs. 20,000 to Rs. 35,000 during the
year w.e.f August 2023. c. Percentage increase in the median remuneration of employees
in the financial year ended March 31,
2024:
There was an increase in the median by 1%. This has been arrived by
comparing the median remuneration of the cost-to-the Company as on March 31, 2024, as
compared to previous year as on March 31, 2023. d. The number of permanent employees on
the rolls of Company: 763 as on March 31, 2024. e. Average percentile increase already made
in the salaries of employees other than the managerial personnel in the last financial
year and its comparison with the percentile increase in the managerial remuneration and
justification thereof and point out if there are any exceptional circumstances for
increase in the managerial remuneration:
There was an increase of 7.49 % in remuneration of employees other than
managerial personnel against 4.69 % increase in remuneration of managerial personnel.
There has been no exceptional remuneration increase for managerial personnel. f.
Affirmation that the remuneration is as per the remuneration policy of the Company:
The Company affirms remuneration is as per the remuneration policy of
the Company. g. The statement containing particulars of top ten employees and the
employees drawing remuneration in excess of limits prescribed under Section 197(12) of the
Act read with Rule 5(2) and (3) of the Companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014 is provided in a separate annexure forming part of this
report and is available on the website of the Company at under Investor section, Financial
Reports. In terms of the proviso to section 136 (1) of the Act, the reports and
accounts are being sent to the shareholders excluding the aforesaid Annexure. Shareholders
interested in obtaining this information may access the same from the Company website or
send a written request to the Company.
In accordance with Section 136 of the Companies Act, 2013, the annexure
is open for inspection at the
Registered Office of the Company during business hours on all working
days, 21 days before the Annual
General Meeting and copies may be made available in request. h. Further
In terms of rule 5 (2) of the Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014 -
1. No employees were employed throughout the financial year, were in
receipt of remuneration for that year which, in the aggregate, was more than One Crore and
Two lakh rupees per annum.
2. No employees were employed for a part of the financial year, was in
receipt of remuneration for any part of that year, at a rate which, in the aggregate, was
more than Eight Lakh and Fifty Thousand Rupees per month.
3. No employees were employed throughout the financial year or part
thereof, who were in receipt of remuneration in that year which, in the aggregate, or as
the case may be, at a rate which, in the aggregate, is in excess of that drawn by the
Managing Director or Whole-Time Director and holds by himself or along with his spouse and
dependent children, not less than two percent of the equity shares of the Company.
12. CERTIFICATIONS ON ISO STANDARDS AND QUALITY FRAMEWORKS
Your Company continues its journey of delivering value to clients
through its rigorous discipline in adhering to ISO Standards and Quality Frameworks.
Sustained commitment to the highest levels of quality and robust information security
practices helped the Company attain significant milestones during the year.
Your Company has adopted and achieved the following international
standards and process improvement framework for process definition and improvement:
ISO 9001-2015
ISO 27001:2022
ISO 20000-1:2018
ISO 14001:2015
Capability Maturity Model Integration (CMMI) Dev V2.0 Maturity Level 5
Your Company has a strong mechanism for taking feedback from the
Customers through satisfaction surveys. The feedback is analyzed across multiple
dimensions to drive improvement in Customer experience.
13. STATE OF COMPANY'S AFFAIRS Strategy
Our strategic objective is to build a sustainable organization that
remains relevant to the agenda of our clients, while generating profitablegrowth for our
investors. During the year, we continued to work on our vision and strengthened focus on
our core competence area of IT services. We also introduced a number of strategies for the
overall growth and productivity of the Company. The following are some of the broad areas
covered by these initiatives:
Cost optimization
A series of measures have been initiated to yield a high level of cost
optimization. This includes increasing the offshore effort ratio, deploying people in
right jobs and eliminating unnecessary costs.
Enhancing sales productivity
There is a considerable focus on the sales team for the purpose of
acquiring large and profitable project. A new sales team is in place to bring more revenue
yielding opportunities.
Delivery
The Delivery team has been strengthened further and it has started
showing immediate results in the form of positive feedback from customers. Our strategy is
to leverage software-based automation to deliver solutions and services to our clients in
the most cost-effective manner, while at the same time optimizing our cost structure to
remain competitive.
14. SUBSIDIARY COMPANIES
The Company has 8 subsidiaries as on March 31, 2024. There are no
associate companies within the meaning of Section 2(6) of the Companies Act, 2013
("Act"). There has been no material change in the nature of the business of the
subsidiaries.
Pursuant to provisions of Section 129(3) of the Act read with rule 5 of
Companies (Accounts) Rules, 2014, as amended from time to time, a statement
containingsalientfeaturesofthefinancialstatements of the Company's subsidiaries in Form
AOC-1 is attached to the financial statements of the Company.
Pursuant to the provisionsofsection136oftheAct,thefinancialstatements
of the Company, consolidated financial statements along with relevant documents and
separate audited accounts in respect of subsidiaries, are available on the website of the
Company at https://www.trigyn.com/investor-relations
15. DIRECTORS RESPONSIBILITY STATEMENT
Pursuant to Section 134 (5) of the Companies Act, 2013, the Board of
Directors, to the best of their knowledge and ability, confirm that: a. in the preparation
of the annual accounts, the applicable accounting standards have been followed and there
are no material departures; b. they have selected such accounting policies and applied
them consistently and made judgments and estimates that are reasonable and prudent so as
to give a true and fair view of the state of affairs of the Company at the end of the
financial year and of the profit of the Company for that period; c. they have taken proper
and sufficientcare for the maintenance of adequate accounting records in accordance with
the provisions of the Act for safeguarding the assets of the Company and for preventing
and detecting fraud and other irregularities; d. they have prepared the annual accounts on
a going concern basis; e. they have laid down internal financial controls to be followed
by the Company and such internal financial controls are adequate and operating
effectively; and f. they have devised proper systems to ensure compliance with the
provisions of all applicable laws and that such systems were adequate and operating
effectively.
Based on the framework of internal financial controls and compliance
systems established and maintained by the
Company, work performed by the internal, statutory and secretarial
auditors and external consultants, including audit of internal financial controls over
financial reporting by the statutory auditors and the reviews performed by management and
the relevant board committees, including the audit committee, the board is of the opinion
that the
Company's internal financial controls were adequate and effective
during the financial year 2023-2024.
16. DIRECTORS AND KEY MANAGERIAL PERSONNEL
In accordance with the provisions of Section 152 of the Companies Act,
2013 and Articles of Association of the Company, Ms. Bhavana Rao, (DIN: 02326788),
Executive Director, shall retire by rotation at ensuing 38th Annual General Meeting of the
Company and being eligible, has offered herself for re-appointment.
Appointments and cessations of Directors & Key Managerial Personnel
are as under: Appointments:
During the year under review, Mr. Ishwar Halalli (DIN No.09781788), Mr.
Vijay Mallya (DIN No.06896919), & Mr. Syed Ahmed Sultan (DIN No. 01928290) as an
Independent Director through Postal Ballot with effect from January 6, 2024.
Cessation:
During the year under review, Mr. Atiqur Rahman Ansari (DIN: 00200187),
resigned as an Independent Director of the Company with effect from January 31, 2024, due
to unavoidable circumstances.
Your Company had appointed following Non-Executive (Independent)
Directors pursuant to Regulation 17 of the Listing Regulations and they are not liable to
retire by rotation as per Companies Act, 2013 (the Act);
1. |
Mr. Atiqur
Rahman Ansari* |
(DIN: 00200187) |
2. |
Mr. Venkata
Cherukuri Varaprasad |
(DIN: 00556469) |
3. |
Mr. Kodumudi
Sambamurthi Sripathi |
(DIN: 02388109) |
4. |
Mr. Vivek
Virendra Khare |
(DIN: 02877606) |
5. |
Dr. Bhiva Rao
Rajdhar Patil |
(DIN: 03279483) |
6. |
Ms. Lakshmi
Potluri |
(DIN: 07382768) |
7. |
Mr. Ishwar
Halalli** |
(DIN: 09781788) |
8. |
Mr. Vijay
Mallya** |
(DIN: 06896919) |
9. |
Mr. Syed Ahmed
Sultan** |
(DIN: 01928290) |
*Mr. A.R Ansari was an Independent Director upto 31st
January 2024
** Mr. Ishwar Halalli, Mr. Syed Ahmed Sultan, and Mr. Vijay Mallya were
appointed as an Independent Director through Postal Ballot with effect from January 6,
2024.
The Company has received declarations from all the Independent
Directors of the Company confirming that they meet with the criteria of independence as
prescribed under sub-section (7) of Section 149 of the Act and Regulation 16 of SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015. In terms of
regulation 34(3) read with schedule V of listing regulations, Company has obtained a
certificate
Company Secretaries confirming that none of the Directors on the Board
have been debarred or disqualified from being appointed or continuing as Director of
company either by SEBI or MCA or any other statutory authorities. The said certificate is
annexed with Annual Report (Annexure III).
During the year, the Non-Executive Directors of the Company had
following pecuniary relationship or transactions with the Company.
Name of
Director |
Sitting
fees + Salary |
Reimbursement for
BOD meeting |
Any other expense
** |
Mr. CH V.V. Prasad |
2.80 |
- |
- |
Mr. Vivek Khare |
5.25 |
- |
0.44 |
Dr. B.R. Patil |
5.25 |
- |
- |
Mr. A. R. Ansari # |
3.85 |
- |
- |
Dr. P. Raja Mohan Rao |
- |
- |
22.08 |
Mr. Kodumudi Sambamurthi Sripathi |
3.15 |
- |
2.12 |
Ms. Bhavana Rao |
- |
- |
0.06 |
Ms. Lakshmi Potluri |
1.05 |
- |
- |
R. Ganapathi* |
1.40 |
- |
108.99 |
Mr Ishwar Halalli |
0.70 |
- |
- |
Mr Syed Ahmed Sultan |
1.05 |
- |
- |
Mr Vijay Mallya |
1.05 |
- |
- |
* Includes Consultancy Fees (in Professional Capacity) Rs. 40.00 Lakhs
& Reimbursement expenses Rs. 68.99 Lakhs ** Includes actual Reimbursement other than
attending the meetings of the Company # Mr. A.R Ansari was an Independent Director upto 31st
January 2024 Sitting Fees has increased from Rs. 20,000 to Rs. 35,000 during the year
w.e.f August 2023.
Criteria of making payments to Non-Executive Directors
Sitting fees is paid to Independent, Woman and Non-Executive Directors.
No sitting fees is paid to Executive Directors for attending the meetings of the Company.
Dr. Raja Mohan Rao, Non-Executive Director has waived his right to receive sitting fees
for attending the board / committee or any other meetings of the Company.
Ms. Bhavana Rao, Executive Director of the Company for the year under
review is an employee of Trigyn Technologies Inc, a wholly owned subsidiary of the Company
and is paid remuneration from the wholly owned subsidiary of the Company. Ms. Bhavana Rao
was appointed as Executive Director of the Company with effect from May 17, 2021 with Nil
Remuneration in your Company.
The Criteria of making payments to Non-Executive Directors can be
viewed at the website of our company at
https://www.trigyn.com/investor-relations/codes-policies/criteria-for-making-payment-of-sitting-fee-to-non-executive-directors
Pursuant to Regulation 46(2) (f) of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015 ("Listing
Regulations"), following are the criteria for making payments to Non executive
Directors of the Company:
Sitting Fee: The Non-executive Director(s) shall receive Sitting
fees for attending meetings of the Board or Committee thereof or any other meeting as may
be required to discharge their duties as Directors not exceeding the limits prescribed
under Companies Act, 2013 read with Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014 as may be applicable from time to time.
Reimbursement of actual expenses incurred: NEDs may also be paid
/ reimbursed such sums incurred as actuals for travel, incidental and / or actual out of
pocket expenses incurred by such Director / Member for attending Board / Committee / any
other meetings / business of the Company.
The above criteria and policy are subject to review by the Nomination
& Remuneration Committee and the Board of Directors of the Company from time to time.
There are no convertible instruments held by or issued to Non-Executive
Director.
Pursuant to the provisions of Section 203 the Key Managerial Personnel
of the Company are Mr. Dilip Hanumara, Chief Executive Office r, upto November 30,
2023.
Ms. Bhavana Rao, Executive Director, Mr. Mukesh Tank, Company Secretary
and Mr. Amin Bhojani, Chief Financial
Officer.
During the year under review, there were above mentioned changes in Key
Managerial Personnel. 17. NUMBER OF MEETINGS OF BOARD
The Company's Board of Directors met five times during the
financial year 2023-2024 and the required information was placed before the Board. The
Board Meetings took place on May 30, 2023, August 11, 2023, November 09, 2023, January 06
2024, and February 08, 2024. For details of the meetings of the Board, please refer to the
corporate governance report, which forms a part of this report.
18. COMMITTEES OF THE BOARD
Currently the Board has five statutory committees, (1) Audit Committee,
(2) Nomination / Remuneration /
Compensation Committee, (3) Corporate Social Responsibility Committee,
(4) Stakeholders Relationship & Grievance Committee and (5) Risk Management Committee.
A detailed note on the Board and its committee is provided under the
Corporate Governance Report section in this Annual Report.
19. BOARD EVALUATION
The Board of Directors have carried out an annual evaluation of its own
performance, Board committees and individual Directors pursuant to the provisions of the
Act and the corporate governance requirements as prescribed by Securities and Exchange
Board of India ("SEBI") under SEBI Listing Regulations, 2015.
The performance of the Board was evaluated by the Board after seeking
inputs from all the Directors on the basis of the criteria such as the Board composition
and structure, effectiveness of Board processes, information and functioning, etc.
The Board and the Nomination / Remuneration / Compensation Committee
("NRC") reviewed the performance of the individual Directors on the basis of the
criteria such as the contribution of the individual Director to the Board and committee
meetings like preparedness on the issues to be discussed, meaningful and constructive
contribution and inputs in meetings, etc. In addition, the Chairman was also evaluated on
the key aspects of his role.
In a separate meeting of Independent Directors, performance of
Non-Independent Directors, performance of the Board as a whole and performance of the
Chairman was evaluated, taking into account the views of Executive Directors and
Non-Executive Directors. The same was discussed in the Board Meeting that followed the
meeting of the Independent Directors, at which the performance of the Board, its
committees and individual Directors was also discussed.
The framework of this evaluation includes but is not limited to the
following parameters:
Peer evaluation
Decision making
Information flows
Board dynamics and relationships
Relationship with stakeholders
Tracking boards and committee's effectiveness
Company's performance and strategy
20. POLICY ON DIRECTOR'S APPOINTMENT AND REMUNERATION AND OTHER
DETAILS.
The Company's policy on Directors' appointment and
remuneration and other matters provided in Section 178(3) of the Act has been disclosed in
the corporate governance report, which forms part of the Directors' Report.
21. INTERNAL FINANCIAL CONTROL SYSTEM AND THEIR ADEQUACY
The details with respect of internal financial control and their
adequacy are included in the Management Discussion
& Analysis, which forms part of this report. 22. AUDIT COMMITTEE
The details pertaining to the composition of the audit committee are
included in the Corporate Governance Report, which forms part of this report.
23. AUDITORS Statutory Auditors
M/s V Rohatgi & Co. Chartered Accounts (Firm Registration No.
000980C) are the Statutory Auditors of the Company.
M/s V Rohatgi & Co. Chartered Accounts has audited the book of
accounts of the Company for the Financial Year ended March 31, 2024, and has issued the
Auditors' Report thereon.
There are no qualifications or reservations or adverse remarks or
disclaimers in the said Report.
Secretarial Auditors
Section 204 of the Companies Act, 2013 inter-alia requires every listed
company to annex with its Board's report, a Secretarial Audit Report given by a
Company Secretary in practice, in the prescribed form. The Board had appointed M/s Anmol
Jha & Associates, practicing Company Secretaries, as Secretarial Auditor to conduct a
Secretarial Audit of the Company for the Financial Year 2023-2024. The said report is
given as Annexure IV.
Regulation 24A of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 requires every listed entity and its material unlisted
subsidiaries incorporated in India shall undertake secretarial audit and shall annex with
its annual report (Annexure V), a secretarial audit report, given by a company
secretary in practice, in such form as may be specified.The Board had appointed M/s VKM
& Associates, practicing Company Secretaries, to issue Annual Secretarial Compliance
Report for the Financial Year ending March 31, 2024.
Internal Auditors
Section 138 of the Companies Act, 2013 and rules made thereunder
requires every listed company to appoint an internal auditor who shall either be a
chartered accountant or a cost accountant, or such other professional as may be decided by
the Board to conduct internal audit of the functions and activities of the company. The
Board had appointed V S Paranjape & Associates LLP, as Internal Auditor to conduct
internal audit of the Company for the Financial Year 2023-2024.
24. AUDITORS REPORT AND SECRETARIAL AUDITORS REPORT
The Statutory Auditors Report does not contain any qualifications,
reservations or adverse remarks .
Secretarial Audit Report of the Secretarial Auditor does not contain
any qualifications, reservations or adverse remarks.
25. REPORTING OF FRAUDS BY AUDITORS
During the year under review, neither the statutory auditors nor the
secretarial auditor has reported to the audit committee, under Section 143 (12) of the
Companies Act, 2013, any instances of fraud committed against the
Company by its officers or employees, the details of which would need
to be mentioned in the Board's report.
26. RISK MANAGEMENT
Risk management is the process of identification, assessment, and
prioritization of risks followed by coordinated efforts to minimize, monitor and
mitigate/control the probability and / or impact of unfortunate events or to maximize the
realization of opportunities. The Board of the Company has formed a risk management
committee to frame, implement and monitor the risk management plan for the Company. The
committee is responsible for reviewing the risk management plan and ensuring its
effectiveness. The audit committee has additional oversight in the area of financial risks
and controls. Major risks identified by the businesses and functions are systematically
addressed through mitigating actions on a continuing basis. The development and
implementation of risk management policy has been covered in the management discussion and
analysis, which forms part of this report.
27. PARTICULARS OF LOANS, GUARANTEES OR INVESTMENTS
The particulars of loans, guarantees and investments have been
disclosed in the financial statements.
28. TRANSACTIONS WITH RELATED PARTY
None of the transactions with related parties falls under the scope of
Section 188(1) of the Act. Information on transactions with related parties pursuant to
Section 134(3)(h) of the Act read with rule 8(2) of the Companies (Accounts) Rules, 2014
are given Form AOC - 2 (Annexure I) and the same forms part of this report.
29. CORPORATE SOCIAL RESPONSIBILITY
In line with the provisions of the Companies Act, 2013, the Company has
framed its Corporate Social Responsibility
(CSR) policy for the development of programs and projects for the
benefit of weaker sections of the society and the same has been approved by the CSR
Committee and the Board of Directors of the Company. The Corporate Social Responsibility
(CSR) policy of the Company provides a road map for its CSR activities. The purpose of CSR
Policy is to devise an appropriate strategy and focus its CSR initiatives and lay down the
broad principles on the basis of which the Company will fulfill its CSR objectives.
Over the years, we have been striving to achieve a fine balance of
economic, environmental and social imperatives, while also paying attention to the needs
and expectations of our internal as well as external stakeholders.
The brief outline of the Corporate Social Responsibility (CSR) Policy
of the Company and the initiatives undertaken by the Company on CSR activities during the
year are set out in Annexure II of this report in the format prescribed in the
Companies (Corporate Social Responsibility Policy) Rules, 2014. The policy is available on
the website of the Company.
30. ANNUAL RETURN
In Compliance of Section 134 (3) (a) and Section 92 (3) of the
Companies Act, 2013 (the Act') , the Annual Return of the Company as on March
31, 2024 in Form MGT-7 is available on the website of the Company at https://www. trigyn.com/investor-relations 31. PREVENTION OF INSIDER TRADING CODE
In compliance with the Securities and Exchange Board of India
(Prohibition of Insider Trading) Regulations, 2015 (the PIT Regulations') on
prevention of insider trading, your Company has in place its Code of Conduct for
regulating, monitoring and reporting of trading by Designated Persons in line with the
amendments brought by SEBI in the PIT Regulations.
Your Company also has a Code of practices and procedures of fair
disclosures of unpublished price sensitive information including a policy for
determination of legitimate purposes along with the Institutional Mechanism for prevention
of insider trading and Policy and procedures for inquiry in case of leak of unpublished
price sensitive information or suspected leak of unpublished price sensitive information.
Your Company has also put in place requisite Structured Digital
Database (SDD) system for the Designated Persons
(DPs) to protect the confidentiality of Unpublished Price Sensitive
Information (UPSI) of the Company.
Further, your Company has in place adequate and effective system to
ensure compliance with the requirements given in these regulations to prevent insider
trading.
32. DISCLOSURE REQUIREMENTS
As per Para C of Schedule V of the SEBI Listing Regulations, corporate
governance report with auditors' certificate thereon and management discussion and
analysis are attached, which form part of this report.
The Company has devised proper systems to ensure compliance with the
provisions of all applicable
Secretarial Standards issued by the Institute of Company Secretaries of
India and that such systems are adequate and operating effectively.
Details of the familiarization programme of the Independent Directors
are available on the website of the Company (URL: https://www.trigyn.com/investor-relations/codes-policies/familiarisation-programme-for-independent-directors
Policy for determining material subsidiaries of the
Company is available on the website of the Company (URL: https://www.trigyn.com/investors/codes-policies/policy-on-material-subsidiaries
Policy on dealing with related party transactions is
available on the website of the Company URL: https://www.
trigyn.com/investor-relations/codes-policies/related-party-transaction-policy The Company has formulated and published a Whistle Blower Policy to
provide Vigil Mechanism for employees including Directors of the Company to report genuine
concerns. The provisions of this policy are in line with the provisions of Section 177(9)
of the Act and Regulation 22 of Listing Regulations, to report concerns about unethical
behavior. The details of the policy have been disclosed in the Corporate Governance
Report, which is a part of this report and also available on https://www.trigyn.com/investor-relations/codes-policies/whistle-blower-policy
33. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION,
FOREIGN EXCHANGE EARNINGS AND OUTGO: A. CONSERVATION OF ENERGY
Your company consumes electricity only for the operation of its
computer and administration of its offices.
Though the consumption of electricity is negligible as compare to the
total turnover of the company, your company always endeavors to take effective steps to
reduce the consumption of electricity.
a) |
The steps taken
or impact on conservation of energy |
N.A. |
b) |
The steps taken
by the company for utilizing alternate sources of energy |
N.A. |
c) |
The capital
investment on energy conservation equipment's |
N.A. |
d) |
Expenditure on
R&D |
N.A. |
B. TECHNOLOGY ABSORPTION
The Company has not absorbed any new technology during the year under
review.
a) |
Efforts made
towards technology absorption |
N.A. |
b) |
Benefits
derived like product improvement, cost reduction, product development or import
substitution |
N.A. |
c) |
Information
regarding Imported Technology |
N.A. |
d) |
Expenditure on
Research and Development |
Nil |
C. FOREIGN EXCHANGE EARNING/OUTGO:
The foreign exchange earnings of your Company during the year were
10,031.55 Lakhs (Previous year
8,849.91 Lakhs), while the outgoings were 399.92 Lakhs (Previous
year 240.12 Lakhs)
The above foreign exchange earnings are excluding Dividend received
during the year in foreign currency
2,911.75 Lakhs (Previous year 2,487.90 Lakhs) 34. EMPLOYEE STOCK
OPTION PLAN (ESOP)
Details required to be provided under the Securities and Exchange Board
of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (SEBI ESOP
Regulations) are not applicable as there are no ESOP schemes or plan operative in your
Company during the year under review.
35. CORPORATE GOVERNANCE AND MANAGEMENT DISCUSSION AND ANALYSIS
REPORT
Your Directors reaffirm their continued commitment to good corporate
governance practices. During the year under review, your Company was in compliance with
the provisions relating to corporate governance as provided under the Listing Regulations.
The compliance report is provided in the Corporate Governance section of this Annual
Report.Theauditor'scertificateon compliance with the conditions of
corporate governance of the Securities and
Exchange Board of India (Listing Requirement and Disclosure
Obligations) Regulations, 2015 (Listing Regulations) forms part of this Report.
36. GREEN INITIATIVES
In terms of the MCA and SEBI Circulars, we are not publishing the
statutory disclosures in the print version of the Annual Report and only the electronic
form is sent to the registered email addresses of the shareholders. Electronic copies of
the Annual Report 2023-2024 and Notice of the 38th Annual General Meeting are
sent to all members whose email addresses are registered with the Company / Depository
Participant(s). For members who have not registered their email addresses can visit the
website of the company https://www.trigyn.com https://ris.kfintech.com
for downloading the Annual Report and Notice of the
e-AGM.
37. ACKNOWLEDGEMENTS
The Directors wish to place on record their appreciation of the
contribution made by employee at all level to the continued growth and prosperity of your
Company.
Your Directors also wish to place on record their appreciation for the
support provided by the Customer, Vendors, Investors, Bankers, SEEPZ, regulatory and
government authorities in India and abroad.
|
For and
on behalf of the Board of Directors |
Place: Chennai |
R. Ganapathi |
Date: August 14, 2024 |
Chairman and
Non-Executive Director |
|
(DIN
00103623) |